Closing the Treatment Gap in Progressive MS
New biomarkers of disease activity may help better vet investigational therapies aimed at slowing the insidious neurodegeneration seen in primary progressive multiple sclerosis.
Treating Medication Overuse Headache: Opportunities for Improvement
A whole-patient approach to management, coupled with new, more targeted treatments, may help reduce the incidence of medication overuse headache.
REM Sleep Behavior Disorder: Predicting Conversion to Synucleinopathy
As a marker of impending neurodegeneration, urgency surrounds efforts to slow or stop the progression of REM sleep behavior disorder.
Small Vessels, Big Impact: The Cerebrovascular Condition You Should Watch For
Addressing risk factors early on may help curb the negative effects of cerebral small vessel disease on aging and reduce risk of neurovascular events.
Tapping Technology to Improve Mental and Cognitive Health in MS
A growing emphasis on access to care and ease of use drives a digital revolution in the treatment of mental comorbidities in multiple sclerosis.
How Much Is Too Much? Debating Blood Pressure Control for Stroke
The benefits of lowering systolic blood pressure for stroke prevention and reducing poststroke disability are numerous, but the ideal target remains elusive.
How Much Is Too Much: Debating Blood Pressure Control for Stroke
